Kolexia
Geier Margaux Pneumologie
Geier Margaux
Pneumologie
Hôpital Morvan
Brest, France
102 Activités
42 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Récidive tumorale locale Métastase tumorale Carcinomes Effets secondaires indésirables des médicaments Carcinome épidermoïde Bronchiolite

Collaborateurs

Voir plus
Descourt Renaud
Descourt Renaud
Hôpital Morvan, Brest, France
Chouaid Christos
Chouaid Christos
Centre Hospitalier Intercommunal Créteil, Créteil, France
Robinet Gilles
Robinet Gilles
Hôpital Morvan, Brest, France
Guisier Florian
Guisier Florian
Hôpital Charles Nicolle, Rouen, France

Industries

Voir plus
CanceroDigest
13 collaboration(s)
Dernière en 2023
AstraZeneca
7 collaboration(s)
Dernière en 2023
B3TSI
6 collaboration(s)
Dernière en 2023
MSD
5 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Incidence of venous thromboembolism and association with PD-L1 expression in advanced non-small cell lung cancer patients treated with first-line chemo-immunotherapy.
Frontiers in oncology   08 janvier 2024
Étude GFPC OBSERVE IIIA-B : analyse prospective des pratiques thérapeutiques françaises dans les cancers bronchiques non à petites cellules de stade III N2
28e Congrès de Pneumologie de Langue Française   01 janvier 2024
Multicentric development and evaluation of FFDG PET/CT and CT radiomic models to predict regional and/or distant recurrence in early-stage non-small cell lung cancer treated by stereotactic body radiation therapy.
European journal of nuclear medicine and molecular imaging   21 novembre 2023
Case Report: Coronaro-bronchial fistula vascularizing a squamous cell lung cancer.
Frontiers in cardiovascular medicine   08 novembre 2023
Venous thrombotic events and impact on outcomes in patients treated with first-line single-agent pembrolizumab in PD-L1 ≥ 50% advanced non small cell lung cancer.
Journal of cancer research and clinical oncology   25 août 2023
GFPC 06-2018: A Multicentre Phase II, Open-label, Non-randomized Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/- Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies
Essai Clinique (Centre François-Baclesse)   31 juillet 2023
Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic non-small-cell lung cancer: A secondary analysis of ESOGIA-GFPC-GECP 08-02 study.
Journal of geriatric oncology   19 mai 2023
Safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer: An open-label phase II trial (VinMetAtezo).
Lung cancer (Amsterdam, Netherlands)   27 février 2023
Pembrolizumab plus pemetrexed-carboplatin combination in first-line treatment of advanced non-squamous non-small cell lung cancer: a multicenter real-life study (CAP29).
Translational lung cancer research   23 février 2023
Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018.
European journal of cancer (Oxford, England : 1990)   31 janvier 2023